San Francisco, CA, United States of America

Julia Winslow Lohman

USPTO Granted Patents = 9 


 

Average Co-Inventor Count = 7.0

ph-index = 6

Forward Citations = 174(Granted Patents)


Location History:

  • Cambridge, MA (US) (2012 - 2013)
  • San Francisco, CA (US) (2013 - 2015)

Company Filing History:


Years Active: 2012-2015

where 'Filed Patents' based on already Granted Patents

9 patents (USPTO):

Title: Celebrating the Innovations of Julia Winslow Lohman

Introduction

Julia Winslow Lohman is an accomplished inventor based in San Francisco, California, who has made significant contributions to the field of pharmaceutical sciences. With a remarkable portfolio that includes nine patents, her work focuses on novel compounds and innovative methods that aim to improve the treatment of various diseases.

Latest Patents

Among her latest patents is the groundbreaking invention titled "Fused Heterocyclic Derivatives and Methods of Use." This patent details a selection of compounds that demonstrate effectiveness for the prophylaxis and treatment of diseases mediated by Hepatocyte Growth Factor (HGF). The invention encompasses novel compounds, analogs, prodrugs, and pharmaceutically acceptable salts, along with methods for prophylaxis and treatment related to conditions such as cancer and other maladies.

Another significant contribution is her patent on "Heterocyclic Compounds and Their Uses," which focuses on substituted bicyclic heteroaryls designed for the treatment of various inflammatory conditions, including arthritis, rheumatic diseases, and autoimmune disorders. This invention also extends to methods for treating cancers that are related to p1 108 activity, which includes various leukemias and solid tumors like breast cancer.

Career Highlights

Julia is currently employed at Amgen Inc., a world-renowned biopharmaceutical company dedicated to transforming the practice of medicine through innovative science. Her work at Amgen reflects her commitment to advancing therapeutic options and improving patient outcomes through her innovative discoveries.

Collaborations

Throughout her career, Julia has collaborated with notable colleagues such as Brian K. Albrecht and David Bauer. These partnerships have enabled her to enhance her research and bring about significant advancements in the treatment of debilitating conditions.

Conclusion

Julia Winslow Lohman stands as a testament to the power of innovation in the pharmaceutical industry. Her impressive body of work, characterized by her commitment to addressing complex medical challenges, continues to have a profound impact on therapeutic practices. With her ongoing research and development, the future looks promising for the advancements emerging from her inventive contributions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…